Muscle Atrophy
Symptoms, Doctors, Treatments, Advances & More

Learn About Muscle Atrophy

What is the definition of Muscle Atrophy?

A stork bite is a common type of birthmark seen in a newborn. It is most often temporary.

The medical term for a stork bite is nevus simplex. A stork bite is also called a salmon patch.

What are the alternative names for Muscle Atrophy?

Salmon patch; Nevus flammeus

What are the causes of Muscle Atrophy?

Stork bites occur in about one third of all newborns.

A stork bite is due to a stretching (dilation) of certain blood vessels. It may become darker when the child cries or the temperature changes. It may fade when pressure is put on it.

What are the symptoms of Muscle Atrophy?

A stork bite usually looks pink and flat. A baby may be born with a stork bite. It may also appear in the first months of life. Stork bites may be found on the forehead, eyelids, nose, upper lip, or back of the neck. Stork bites are purely cosmetic and do not cause any symptoms.

Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Muscle Atrophy?

No treatment is needed. If a stork bite lasts longer than 3 years, it may be removed with a laser to improve the person's appearance.

Who are the top Muscle Atrophy Local Doctors?
Elite in Muscle Atrophy
Elite in Muscle Atrophy

Office

185 Cambridge St, 
Boston, MA 
Languages Spoken:
English

Kathryn Swoboda is a Neurologist practicing medicine in Boston, Massachusetts. Dr. Swoboda is rated as an Elite provider by MediFind in the treatment of Muscle Atrophy. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Primary Lateral Sclerosis, Spinal Muscular Atrophy (SMA), Muscle Atrophy, and Alternating Hemiplegia of Childhood.

Elite in Muscle Atrophy
Elite in Muscle Atrophy
Robert Koch Str. 40, 
Goettingen, NI, DE 

Stephan Von Haehling practices practicing medicine in Goettingen, Germany. Mr. Von Haehling is rated as an Elite expert by MediFind in the treatment of Muscle Atrophy. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Heart Failure, Muscle Atrophy, Iron Deficiency Anemia, Heart Failure with Preserved Ejection Fraction (HFpEF), and Tissue Biopsy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Muscle Atrophy
Elite in Muscle Atrophy
Maastricht, LI, NL 

Annemie Schols practices practicing medicine in Maastricht, Netherlands. Schols is rated as an Elite expert by MediFind in the treatment of Muscle Atrophy. They are also highly rated in 7 other conditions, according to our data. Their clinical expertise encompasses Muscle Atrophy, Chronic Obstructive Pulmonary Disease (COPD), Cerebral Hypoxia, Non-Small Cell Lung Cancer (NSCLC), and Gastrostomy.

What is the outlook (prognosis) for Muscle Atrophy?

Most stork bites on the face go away completely in about 18 months. Stork bites on the back of the neck usually do not go away.

When should I contact a medical professional for Muscle Atrophy?

Your provider should look at all birthmarks during a routine well-baby exam.

How do I prevent Muscle Atrophy?

There is no known prevention.

What are the latest Muscle Atrophy Clinical Trials?
Safety and Performance of the ThecaFlex DRx™ System Port and Catheter for Chronic Intrathecal Access, Cerebrospinal Fluid (CSF) Aspiration, and DElivery of Nusinersen in Spinal Muscular Atrophy (SMA) Patients Resistant to Lumbar PunctuRE Trial (PIERRE)

Summary: The primary objective of the clinical investigation is to demonstrate successful clinical use of the ThecaFlex DRx™ System in delivering nusinersen in subjects with spinal muscular atrophy (SMA). All enrolled subjects will undergo implantation of the investigational device (ThecaFlex DRx™ System) and will be followed for 12 months after receiving the implant. The 12-month data will be used to asse...

Match to trials
Find the right clinical trials for you in under a minute
Get started
The Effects of Tirzepatide Use on Muscle and Vascular Function Among Obese Older Adults

Summary: Obesity and type 2 diabetes mellitus (T2DM) represent major public health concerns in the aging community. Tirzepatide, a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist recently approved for the treatment of T2DM and obesity has been shown to be effective at reducing weight, improving markers of T2DM control, and improving cardiov...

What are the Latest Advances for Muscle Atrophy?
Tired of the same old research?
Check Latest Advances
Who are the sources who wrote this article ?

Published Date: April 01, 2025
Published By: Linda J. Vorvick, MD, Clinical Professor Emeritus, Department of Family Medicine, UW Medicine, School of Medicine, University of Washington, Seattle, WA. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Dinulos JGH. Vascular tumors and malformations. In: Dinulos JGH, ed. Habif's Clinical Dermatology: A Color Guide in Diagnosis and Therapy. 7th ed. Philadelphia, PA: Elsevier; 2021:chap 23.

Moon M, Guerrero AM, Li X, Koch E, Gehris RP. Dermatology. In: Zitelli BJ, McIntire SC, Nowalk AJ, Garrison J, eds. Zitelli and Davis' Atlas of Pediatric Physical Diagnosis. 8th ed. Philadelphia, PA: Elsevier; 2023:chap 8.

Younger SB, Martin KL. Dermatologic diseases of the neonate. In: Kliegman RM, St Geme JW, Blum NJ, et al, eds. Nelson Textbook of Pediatrics. 22nd ed. Philadelphia, PA: Elsevier;2025:chap 688.